Table 3.
Pre-Treatment VAF | Post-Treatment VAF | p-Value | |
---|---|---|---|
Cancer-specific death | |||
TERT c.-124C>T | 159% | 34% | 0.09 |
TERT c.-146C>T | 8% | 0% | 0.23 |
ATM c.1236-2A>T | 1% | 1% | 0.55 |
TP53 c.853G>A | 83% | 8% | 0.11 |
Remaining patients | |||
TERT c.-124C>T | 12% | 7% | 0.15 |
TERT c.-146C>T | 16% | 9% | 0.33 |
ATM c.1236-2A>T | 5% | 5% | 0.41 |
TP53 c.853G>A | 73% | 81% | 0.20 |